October 24, interim report
July – September 2024
Alligator hosted a webinar on Thursday, October 24, at 3 p.m. CEST for investors, analysts and media, where CEO Søren Bregenholt and CFO Johan Giléus presented and commented on the Q3 interim report, which was followed by a Q&A session.
The call was held in English, and can be requested below.
LATEST NEWS
Change in number of shares and votes in Alligator Bioscience
During the month of December, the number of shares and votes in Alligator Bioscience AB has changed due to conversion of a total of 170,681 …
Alligator Bioscience AB announces outcome of exercise of warrants series TO 9
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, J …
Last day of trading in warrants series TO 9 in Alligator Bioscience AB is 13 December 2024
13 December 2024 is the last day of trading in warrants series TO 9 in Alligator Bioscience AB (“Alligator Bioscience” or the &# …